Skip to main content
Premium Trial:

Request an Annual Quote

Good Start Genetics Expands Hopkins Aneuploidy Screening License to Enter NIPT Market

NEW YORK (GenomeWeb) – Good Start Genetics has expanded its exclusive license of an aneuploidy screening test and related know-how from Johns Hopkins University to include applications in noninvasive prenatal testing, the company said today.

Last December, Good Start Genetics licensed the approach, called FAST-SeqS for Fast Aneuploidy Screening Test-Sequencing System, for preimplantation genetic screening of embryos.

At the time, the company said that FAST-SeqS, which was developed by Hopkins researchers and published in 2012, may have applications beyond PGS, including prenatal testing.

Good Start Genetics President and CEO Don Hardison said in a statement that the company has been pleased with its early experience with FAST-SeqS for PGS and believes the technology and an ongoing collaboration with Hopkins researchers "offer great promise in NIPT, enabling easier workflows, lower costs and broader accessibility for patients."

FAST-SeqS uses a single primer pair to amplify distinct sections of the genome that occur on every chromosome and will be applied to maternal plasma DNA as part of a NIPT.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.